LLY

710.61

+0.3%↑

JNJ

179.04

+0.08%↑

ABBV

210.25

+0.41%↑

UNH

306.92

+1.28%↑

AZN

80.93

+0.65%↑

LLY

710.61

+0.3%↑

JNJ

179.04

+0.08%↑

ABBV

210.25

+0.41%↑

UNH

306.92

+1.28%↑

AZN

80.93

+0.65%↑

LLY

710.61

+0.3%↑

JNJ

179.04

+0.08%↑

ABBV

210.25

+0.41%↑

UNH

306.92

+1.28%↑

AZN

80.93

+0.65%↑

LLY

710.61

+0.3%↑

JNJ

179.04

+0.08%↑

ABBV

210.25

+0.41%↑

UNH

306.92

+1.28%↑

AZN

80.93

+0.65%↑

LLY

710.61

+0.3%↑

JNJ

179.04

+0.08%↑

ABBV

210.25

+0.41%↑

UNH

306.92

+1.28%↑

AZN

80.93

+0.65%↑

Начало・Списък с акции・Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc

Затворен

СекторЗдравеопазване

413.26 1.67

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

402.44

Максимум

419.28

Ключови измерители
By Trading Economics
Приходи	31M -42M
Продажби	76M 213M
EPS	-1.9
Марж на печалбата	-19.869
Служители	528
EBITDA	31M -39M

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+12.16% upside

Дивиденти
By Dow Jones
Следващи печалби	30.10.2025 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	1.8B 8.7B
Предишно отваряне	411.59
Предишно затваряне	413.26

Настроения в новините

By Acuity

61%

39%

321 / 372 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

263.2 / 277.1 Подкрепа & съпротива

Madrigal Pharmaceuticals Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

22.08.2025 г., 23:09 ч. UTC

Придобивния, сливания и поглъщания

Trump Says U.S. Will Take Nearly 10% Equity Stake in Intel -- 4th Update

22.08.2025 г., 22:02 ч. UTC

Придобивния, сливания и поглъщания

Agreement Could Also Lead to Deeper Collaboration Between CSX, BNSF

22.08.2025 г., 22:02 ч. UTC

Придобивния, сливания и поглъщания

Some Analysts Say Agreement Suggests Lack of Confidence in Merger

22.08.2025 г., 22:02 ч. UTC

Придобивния, сливания и поглъщания

CSX, BNSF Intermodal Pact Draws Competing Views on Merger Possibility

22.08.2025 г., 22:02 ч. UTC

Придобивния, сливания и поглъщания

CSX, BNSF Pact Sparks Debate on Whether Another Rail Merger Is Approaching -- Analysis

22.08.2025 г., 22:02 ч. UTC

Придобивния, сливания и поглъщания

Pact Could Show Regulators That Transcontinental Service Can Come Without Merger

22.08.2025 г., 21:23 ч. UTC

Пазарно говорене

Moody's Lowers Outlook on Austria to Negative From Stable -- Market Talk

22.08.2025 г., 21:18 ч. UTC

Пазарно говорене

US Economic Growth Seen Slowing This Year -- Market Talk

22.08.2025 г., 21:18 ч. UTC

Придобивния, сливания и поглъщания

U.S. Takes 10% Stake in Intel -- Barrons.com

22.08.2025 г., 21:03 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

22.08.2025 г., 21:03 ч. UTC

Пазарно говорене

Mexican Stocks Close At Record High -- Market Talk

22.08.2025 г., 20:58 ч. UTC

Пазарно говорене

US General Government Deficit Expected to Rise in 2026, 2027 -- Market Talk

22.08.2025 г., 20:57 ч. UTC

Придобивния, сливания и поглъщания

Intel: Government's Investment in Intel Will Be a Passive Ownership, With No Bd Representation or Other Governance or Info Rights >INTC

22.08.2025 г., 20:57 ч. UTC

Придобивния, сливания и поглъщания

Intel: Government Also Agrees to Vote With the Company's Bd of Directors on Matters Requiring Shareholder Approval, With Limited Exceptions >INTC

22.08.2025 г., 20:57 ч. UTC

Придобивния, сливания и поглъщания

Intel: Government Equity Stake Will Be Funded by Remaining $5.7B in Grants Previously Awarded, But Not Yet Paid, Under U.S. CHIPS and Science Act and $3.2B Awarded as Part of Secure Enclave Program >INTC

22.08.2025 г., 20:57 ч. UTC

Придобивния, сливания и поглъщания

Intel: Government Agrees to Purchase 433.3M Primary Shrs of Intel Common Stk at a Price of $20.47 per Shr, Equivalent to a 9.9% Stake in Co >INTC

22.08.2025 г., 20:57 ч. UTC

Придобивния, сливания и поглъщания

Intel: U.S. Government to Make $8.9B Investment in Intel Common Stk as Co Builds Upon Its More Than $100B Expansion of Resilient Semiconductor Supply Chain >INTC

22.08.2025 г., 20:57 ч. UTC

Придобивния, сливания и поглъщания

Intel: Intel and Trump Admin Reach Historic Agreement to Accelerate Amer Technology and Manufacturing Leadership

22.08.2025 г., 20:56 ч. UTC

Печалби

These Stocks Moved the Most Today: Nvidia, Builders FirstSource, Zoom, Intuit, Workday, BJ's, Ubiquiti, and More -- Barrons.com

22.08.2025 г., 20:55 ч. UTC

Печалби

These Stocks Are Moving the Most Today: Nvidia, Builders FirstSource, Zoom, Intuit, Workday, BJ's, Ubiquiti, and More -- Barrons.com

22.08.2025 г., 20:50 ч. UTC

Пазарно говорене

Печалби

Tech, Media & Telecom Roundup: Market Talk

22.08.2025 г., 20:50 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Basic Materials Roundup: Market Talk

22.08.2025 г., 20:41 ч. UTC

Придобивния, сливания и поглъщания

U.S. Has 10% Stake in Intel, Lutnick Says -- Barrons.com

22.08.2025 г., 20:24 ч. UTC

Придобивния, сливания и поглъщания

Trump Says U.S. Will Take Nearly 10% Equity Stake in Intel -- 3rd Update

22.08.2025 г., 20:16 ч. UTC

Придобивния, сливания и поглъщания

CSX and Warren Buffett's BNSF Made News. Why Investors Are Disappointed. -- Barrons.com

22.08.2025 г., 19:19 ч. UTC

Пазарно говорене

Boeing to Restart Talks With Defense Workers' Union Monday -- Market Talk

22.08.2025 г., 19:10 ч. UTC

Пазарно говорене

Oil Futures Gain as Russia-Ukraine Peace Seems Distant -- Market Talk

22.08.2025 г., 19:06 ч. UTC

Пазарно говорене

U.S. Natural Gas Extends Losses as Summer Nears an End -- Market Talk

22.08.2025 г., 19:03 ч. UTC

Пазарно говорене

Lower Borrowing Rates Elusive Even if Fed Cuts -- Market Talk

22.08.2025 г., 18:52 ч. UTC

Придобивния, сливания и поглъщания

Trump Says U.S. Will Take Nearly 10% Equity Stake in Intel -- 2nd Update

Сравнение с други в отрасъла

Ценова промяна

Madrigal Pharmaceuticals Inc Прогноза

Ценова цел

By TipRanks

12.16% нагоре

12-месечна прогноза

Среден 456.6 USD 12.16%

Висок 567 USD

Нисък 266 USD

Според 12 анализатори от Wall Street, предложили 12-месечна ценова цел за Madrigal Pharmaceuticals Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

12 ratings

Купи

Задържане

Продай

Според 12 анализатори, дали борсови рейтинги на Madrigal Pharmaceuticals Inc през последните 3 месеца.

Техническа оценка

By Trading Central

263.2 / 277.1Подкрепа & съпротива

Bearish events outweigh bullish events.

Recent bearish events outweigh bullish events.

The bullish and bearish events are balanced.

Настроение

By Acuity

321 / 372 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH. The company is headquartered in West Conshohocken, Pennsylvania.